Lower-dose prescriptions in the post-marketing situation and the influencing factors thereon.
The dosage of pharmaceuticals is determined through the process of clinical development and approval review based on clinical trial results; however, the information obtained from clinical trials before approval is limited. Some pharmaceutical products are used at doses lower than those approved for...
Main Authors: | Akiko Ogata, Masayuki Kaneko, Mamoru Narukawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0218534 |
Similar Items
-
Closed Sets and Operators thereon: Representations, Computability and Complexity
by: Carsten Rösnick-Neugebauer
Published: (2018-04-01) -
Factors associated with successful phase III trials for solid tumors: A systematic review
by: Yasushi Otsuka, et al.
Published: (2021-12-01) -
Neovascularization after ischemic conditioning of the stomach and the influence of follow-up neoadjuvant chemotherapy thereon
by: Vadim Prudius, et al.
Published: (2018-05-01) -
Post award arbitral tribunal's mandate under the UNCITRAL Model Law and national laws based thereon
by: Omar Hisham Al Hyari, et al.
Published: (2021-07-01) -
The effect of swimming exercise on adenine-induced kidney disease in rats, and the influence of curcumin or lisinopril thereon.
by: Badreldin H Ali, et al.
Published: (2017-01-01)